{{Rsnum
|rsid=7521
|Gene=MAPT
|Chromosome=17
|position=46028029
|Orientation=plus
|GMAF=0.3173
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 18.6 | 48.7 | 32.7
| HCB | 0.0 | 21.2 | 78.8
| JPT | 0.9 | 18.6 | 80.5
| YRI | 17.7 | 51.7 | 30.6
| ASW | 17.5 | 49.1 | 33.3
| CHB | 0.0 | 21.2 | 78.8
| CHD | 1.8 | 15.6 | 82.6
| GIH | 33.7 | 47.5 | 18.8
| LWK | 18.2 | 53.6 | 28.2
| MEX | 6.9 | 48.3 | 44.8
| MKK | 17.3 | 46.8 | 35.9
| TSI | 14.7 | 40.2 | 45.1
| HapMapRevision=28
}}{{PMID Auto
|PMID=19450659
|Title=Microtubule-Associated Protein Tau (MAPT) Influences the Risk of Parkinson's Disease Among Indians
}}

{{PMID Auto
|PMID=20951764
|Title=High cerebrospinal tau levels are associated with the rs242557 tau gene variant and low cerebrospinal ?-amyloid in Parkinson disease
}}

{{PMID Auto
|PMID=17192721
|Title=Association of tau haplotype-tagging polymorphisms with Parkinson's disease in diverse ethnic Parkinson's disease cohorts.
}}

{{PMID Auto
|PMID=17266761
|Title=Haplotype-based association analysis of the MAPT locus in late onset Alzheimer's disease.
|OA=1
}}

{{PMID Auto
|PMID=18065436
|Title=The tauopathy associated with mutation +3 in intron 10 of Tau: characterization of the MSTD family.
|OA=1
}}

{{PMID Auto
|PMID=18072964
|Title=No evidence for association between tau gene haplotypic variants and susceptibility to Creutzfeldt-Jakob disease.
|OA=1
}}

{{PMID Auto
|PMID=18541914
|Title=Variation in MAPT is associated with cerebrospinal fluid tau levels in the presence of amyloid-beta deposition.
|OA=1
}}

{{PMID Auto
|PMID=19558713
|Title=Role of the H1 haplotype of microtubule-associated protein tau (MAPT) gene in Greek patients with Parkinson's disease.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}